The Commercialization EPI-Center seeks to purposefully commercialize university inventions and discoveries, often by working with an external partner or through the development of an entirely new company.
The EPI-Center works with external organizations ranging from international corporations to local startups.
This can take many forms, from a technology license to a full-fledged partnership to further develop the technology. In short, no matter an organization’s unique needs or circumstances, the EPI-Center team will strive to craft a flexible, individual deal-focused agreement that benefits everyone.
While the licensing process is a large part of the EPI-Center’s activities, our team also performs additional functions to help bridge the gap between lab and license, mind and market.
The EPI-Center actively seeks to advance entrepreneurial efforts of university members by licensing technologies to those with early-stage companies, connecting entrepreneurs to industry stakeholders, educating the public on startup resources and encouraging new discoveries through prestigious translational research programs.
- Lung Cancer Diagnostic System: Rapid, Non-Invasive CAD System for Detecting EarlyStage Lung Carcinoma (18032)
- Personalized Diagnosis of Early Alzheimer's Disease: Computer Aided Diagnosis System for Mild Cognitive Impairment (18068)
- Precise Segmentation for CAD: Framework Combining 7th-Order MGRF Model with Adaptive Shape for Improved Accuracy (17046)
- Surface Electropolishing for Complex Geometries: Electrochemical surface treatment; Additive manufacturing (18077)
- UofL Cancer-Targeting Technology Licensed to California Medical Company
- UofL-born Technology Startup Acquired by Global Firm
- UofL Milk-Based Drug Delivery Technology Licensed